Upload
hendrianto-maleen
View
228
Download
0
Embed Size (px)
Citation preview
8/2/2019 Clinical Pharmacokinetic
1/22
Click to edit Master subtitle style
4/16/12
GROUP 8
ZELVI AFIZA(0911011012)RIZKI FEBRIKA PUTRI
(0911012054)ALMUKRAMIN(0911012057)WINDHA WULAN NDARI(0911012074)
Clinical Pharmacokinetic
AMINOPHYLLINE
8/2/2019 Clinical Pharmacokinetic
2/22
4/16/12
Aminophylline
Aminophylline is a 2:1 complex oftheophylline and ethylenediamine.
Theophylline is structurally classified asa methylxanthine. Aminophylline occursas a white or slightly yellowish granuleor powder, with a slight ammoniacalodor. Aminophylline has the chemical
name 1H-Purine-2, 6-dione, 3,7-dihydro-1,3-dimethyl-, compound with 1,2-ethanediamine (2:1). The structuralformula of aminophylline (dihydrate) is
as follows:
8/2/2019 Clinical Pharmacokinetic
3/22
4/16/12
The molecular formula of
aminophylline dihydrate is
C16H24N10O4 2(H2O) with
a molecular weight of 456.46.
Aminophylline Synonymous with
theophylline ethylenediamine,AminophyllinAminophylline AnhydrousAminophylline DihydrateAminophylline Dye Free
8/2/2019 Clinical Pharmacokinetic
4/22
4/16/12
Pharmacology ofAminophylline
A bronchodilator, aminophylline is aderivative of theophylline. Bothaminophylline and theophylline are
methylxanthines and are derived fromthe group called Xanthines. The drugaminophylline differs somewhat in itsstructure from theophylline in that it
contains ethylenediamine, as well asmore molecules of water.Aminophylline tends to be a less
potent and shorter acting than
8/2/2019 Clinical Pharmacokinetic
5/22
4/16/12
Indications
Used as a bronchodilator in reversible airwayobstruction due to asthma. May be used incases of Pulmonary edema and pulmonarycongestion secondary to heart failure. Helpful inrats with pneumonia.
Therapeutic Uses:1. Bronchodilator in reversible airway
obstruction caused by asthma or COPD.
2. Asthma3. COPD
4. Apnea of Prematurity
5. Target serum levels for COPD are 10-12mg/ml
8/2/2019 Clinical Pharmacokinetic
6/22
4/16/12
Mode of Action:
The precise mechanism of action is
unknown. It is thought to be aphosphodiesterase inhibitor which may givea bronchodilatory effect. It also bindsadenosine receptors. Aminophylline may
also increase diaphragm strength andimprove stimulation of the ventilatory drive
Measure of Action:
1. Blood Pressure
8/2/2019 Clinical Pharmacokinetic
7/22
4/16/12
Contraindications:
1. Hypersensitivity to Aminophylline or
Theophylline
2. Cardiac arrhythmias
3. Cigarette smoking is also known to
decresase theophylline levels
. Side effects or precautions:
1. Atrial flutter; Tachycardia
2. Headache; Insomnia; Irritability; Results;Seizures
3. Diarrhea; Nausea; Vomitin
8/2/2019 Clinical Pharmacokinetic
8/22
4/16/12
6. The therapeutic range forTheophylline is less than 20 mg/ml.
Anything over 20mg/ml can havetoxic side effects.
7. >20mg/ml=Nausea
8. >30mg/ml= Cardiac arrhythmias
9. 40-45mg/ml= Seizures
Pharmacodynamics Aminophylline isthe ethylenediamine salt of
theophylline. Theophylline
8/2/2019 Clinical Pharmacokinetic
9/22
4/16/12
Mechanism of action Theophylline isstructurally related to theobromine and
caffeine. The precise mechanism ofaction of theophylline is not known,however, it is thought to be a
phosphodiesterase inhibitor which maygive a bronchodilatory effect. It alsobinds adenosine receptors.
Categories
Phosphodiesterase Inhibitors
Bronchodilator A ents
8/2/2019 Clinical Pharmacokinetic
10/22
4/16/12
Pharmacokinetics Absorption although absorption may
be slow given orally and not aseffective as when given parenterally.
Absorbed orally (given after meals) Metabolized in the liver by Cyt P450enzymes ( t = 8 h )
T is decreased by
Enzyme inducers (phenobarbitone-rifampicin)
T is increased by
Enzyme inhibitor (cimetidine, erythromycin)
8/2/2019 Clinical Pharmacokinetic
11/22
4/16/12
Pharmacokinetics cont.
Protein binding 60%
Half life 7-9 hours
The drug aminophylline differssomewhat in its structure fromtheophylline in that it contains
ethylenediamine, as well as moremolecules of water. Aminophyllinetends to be a less potent and shorteracting than theophylline. They also
cross the placental barrier.
8/2/2019 Clinical Pharmacokinetic
12/22
4/16/12
Clearance
0.29 mL/kg/min [postnatal age 3-15days]
0.64 mL/kg/min [postnatal age 25-57days]
1.7 mL/kg/min [ 1-4 years]
1.6 mL/kg/min [4-12 years]
0.9 mL/kg/min [13-15 years]
1.4 mL/kg/min [16-17 years]
8/2/2019 Clinical Pharmacokinetic
13/22
4/16/12
Food And Drugs Interactions
Interferon alfa-n1 Interferon increasesthe effect and toxicity of theophylline
Erythromycin The macrolide,
erythromycin, may increase the effectand toxicity of the theophyllinederivative, aminophylline
Ticlopidine Ticlopidine increases theeffect and toxicity of theophylline
Temazepam Aminophylline may
decrease the efficacy of Temazepam.nit r r h n in th th r ti
8/2/2019 Clinical Pharmacokinetic
14/22
4/16/12
Butalbital The barbiturate, butalbital,decreases the effect of aminophylline.
Phenytoin Decreased effect of bothproducts
Pentobarbital The barbiturate,pentobarbital, decreases the effect ofaminophylline.
Sotalol Antagonism of action andincreased effect of theophylline
Cimetidine Cimetidine may increasethe serum concentration ofaminophylline by decreasing its
8/2/2019 Clinical Pharmacokinetic
15/22
4/16/12
Carbamazepine Carbamazepine may
decrease the serum concentration ofaminophylline. Aminophylline maydecrease the serum concentration ofcarbamazepine. Monitor for changes inthe therapeutic effect of both agents ifconcomitant therapy is initiated,discontinued or dose changed.
Propranolol Antagonism of action andincreased effect of theophylline
Adenosine This xanthine decreases theeffect of adenosine
8/2/2019 Clinical Pharmacokinetic
16/22
4/16/12
Food Interactions Limit caffeineintake.
Take with food.
Vitamin B6 needs increased,
supplement recommended.
Doses:
Adult dose for acute asthma: IV:
Loading Dose: 6 mg/kg in 100 to 200
mL of IV fluid intravenously once
8/2/2019 Clinical Pharmacokinetic
17/22
4/16/12
Oral:Loading dose: 6.3 mg/kg orally once.Maintenance Dose: Otherwise healthynonsmoking adult: 12.5 mg/kg/day individed doses. Do not exceed 1,125mg/day.Young adult smoker: 19
mg/kg/day in divided doses.Patientwith cor pulmonale or congestive heartfailure: 6.25 mg/kg/day in divided
doses. Do not exceed 500 mg/day.
Pediatric Dose for Apnea of
Prematurity:
8/2/2019 Clinical Pharmacokinetic
18/22
4/16/12
Pediatric Dose for Acute Asthma:
IV:Loading dose: 6 mg/kg diluted in IVfluid intravenously once over 20 to 30minutes.Maintenance dose: 6 weeks to 6months: 0.5 mg/kg/hour continuousintravenous infusion.6 months to 1
year: 0.6 to 0.7 mg/kg/hr continuousintravenous infusion.1 year to 9 years:1 to 1.2 mg/kg/hr continuous
intravenous infusion.9 years to 12
8/2/2019 Clinical Pharmacokinetic
19/22
4/16/12
Oral:Loading dose: 6.3 mg/kg orally once.Maintenance dose: >=42 < 182days: 12 to 13.5 mg/kg/day individed doses.>= 6 < 12 months: 15
to 22.5 mg/kg/day in divideddoses.>=1 year to =9
years to =12 to=16 years: 6.25 to 20 mg/kg
orally divided every 6 hours.
8/2/2019 Clinical Pharmacokinetic
20/22
4/16/12
Intravenous AdmixtureIncompatibility:
Although there have been reports ofaminophylline precipitating in acidicmedia, these reports do not apply tothe dilute solutions found inintravenous infusions. Aminophyllineinjection should not be mixed in a
syringe with other drugs but shouldbe added separately to theintravenous solution.
When an intravenous solution
8/2/2019 Clinical Pharmacokinetic
21/22
4/16/12
Dose Adjustments
Liver Dose Adjustments
Loading dose: 6 mg/kg (patient notreceiving aminophylline ortheophylline) diluted in IV fluid at arate not more than 25 mg/min.Maintenance dose: 0.25 mg/kg/hr
continuous intravenous infusion. In patients receiving theophylline,
each 0.5 mg/kg theophylline (0.6
mg/kg aminophylline) administered
8/2/2019 Clinical Pharmacokinetic
22/22
4/16/12
Dose Adjustments cont
Dialysis
Aminophylline (theophylline) issomewhat removed with hemodialysis.A 50% supplemental dose oradministering the dose post dialysis isrecommended. A supplemental dose is
not needed with peritoneal dialysis Serum levels may be obtained 15 to
30 minutes following an IV loading
dose